BioSante signs licensing deal
LINCOLNSHIRE -- BioSante Pharmaceuticals Inc. on Monday announced it has signed a license agreement covering the use of BioSante's calcium phosphate nanotechnology as a facial filler in aesthetic medicine.
The license was signed with Medical Aesthetics Technology Corp. Under the agreement, Medical Aesthetics is responsible for continued development of BioLook, including required clinical trials, regulatory filings and all manufacturing and marketing. In exchange for this license, BioSante has taken a 5.5 percent ownership position in the company.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.